Neurology News and Research

Latest Neurology News and Research

Autism Consortium holds its fourth annual symposium to update on autism

The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston.

6 Nov 2009

People with MS who relapse within first five years of onset have more severe disability: Study

People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according to a new study published in the November 4, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the first to examine how MS relapses affect people during different time periods of the disease.

5 Nov 2009

Takeda Pharmaceuticals strengthens its North American market

Takeda Pharmaceuticals North America, Inc., today announced the incorporation of Takeda Pharmaceuticals Mexico, S.A. de C.V. This expansion strengthens the company's North American presence, bolstering existing operations in the United States and Canada. Takeda Pharmaceuticals Mexico will be headquartered in Mexico City.

4 Nov 2009

Inner sense of cardiovascular state relies on two independent pathways, shows study

A new study suggests that the inner sense of our cardiovascular state, our "interoceptive awareness" of the heart pounding, relies on two independent pathways, contrary to what had been asserted by prominent researchers.

4 Nov 2009

Brain disorder that causes early dementia is highly hereditary: Study

New research shows that a rare brain disorder that causes early dementia is highly hereditary. The study is published in the November 3, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.

3 Nov 2009

St. David's Medical Center to use FDA cleared CARTO 3 Navigation System for treating cardiac arrhythmia

On Monday, November 2, 2009, Andrea Natale, M.D., F.A.C.C., F.H.R.S., an electrophysiologist and executive medical director of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, will be the first physician in the United States to perform an ablation procedure to treat a patient with a cardiac arrhythmia, commonly known as an irregular heart rhythm, using the newly FDA-cleared CARTO® 3 Navigation System.

2 Nov 2009

Cooper Norcross Run the Bridge: More than 4,000 runners participate to support school for the disabled

More than a record 4,000 runners and walkers participated in yesterday’s Cooper Norcross Run the Bridge, presented by AmeriHealth New Jersey.

2 Nov 2009

Valeant Pharmaceuticals announces financial results for the third quarter of 2009

Valeant Pharmaceuticals International today announced third quarter financial results for 2009.

2 Nov 2009

Natus Medical announces a revenue of $44.3M for the third quarter of 2009

Natus Medical Incorporated today announced financial results for the three and nine months ended September 30, 2009.

2 Nov 2009

New teleneurology medicine program to provide 24-hour emergency services launched

Rural and small, suburban hospitals in North Carolina and Virginia can now provide a higher level of emergency stroke and critical neurology care, 24 hours a day, 365 days a year, as part of a new teleneurology medicine program announced Oct. 26, 2009, by Forsyth Medical Center (FMC).

31 Oct 2009

Data from multiple clinical and preclinical studies evaluating Hematide announced

Affymax, Inc. and Takeda Pharmaceutical Global Research & Development Center, Inc., today announced data from multiple clinical and preclinical studies evaluating Hematide, including preliminary results of a Phase 2 trial which demonstrated that Hematide increased hemoglobin levels in a group of anemic hemodialysis (HD) patients.

31 Oct 2009

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN).

30 Oct 2009

Valeant Pharmaceuticals to acquire prescription and cosmetic products rights from Polish

Valeant Pharmaceuticals International (NYSE: VRX) today announced that it has agreed to acquire the rights to several prescription and cosmetic dermatology products from a privately-held, Polish specialty pharmaceutical company.

30 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

ExonHit Therapeutics yesterday presented clinical data on the validation set “Alzheimer patients versus healthy controls” for AclarusDx™ (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimer’s disease (AD), at the 2nd Conference of Clinical Trials on Alzheimer’s Disease (CTAD) in Las Vegas, USA.

30 Oct 2009

Case Western Reserve awarded $14.7M to lead study on effects of lowering systolic blood pressure

Case Western Reserve University School of Medicine has received a $14.7 million, nine-year contract from the National Institutes of Health to be one of five institutions to lead a trial to determine if lowering systolic blood pressure in hypertensive patients, without diabetes, to below the currently recommended level can reduce the incidence of cardiovascular and kidney disease and slow cognitive decline.

30 Oct 2009

Research project to improve early diagnosis and treatment of mild traumatic brain injuries

With financial backing from a leading nonprofit supporter of military medical research, medical device manufacturer Neuro Kinetics, Inc. (www.neuro-kinetics.com) said today that it is collaborating with the U.S. Army Aeromedical Research Laboratory (USAARL) at Fort Rucker, Alabama, and three other military medical facilities in a comprehensive research project to improve early diagnosis and treatment of mild traumatic brain injuries (mTBI).

30 Oct 2009

Neurology News and Research

Latest Neurology News and Research

Autism Consortium holds its fourth annual symposium to update on autism

People with MS who relapse within first five years of onset have more severe disability: Study

Takeda Pharmaceuticals strengthens its North American market

Inner sense of cardiovascular state relies on two independent pathways, shows study

Brain disorder that causes early dementia is highly hereditary: Study

St. David's Medical Center to use FDA cleared CARTO 3 Navigation System for treating cardiac arrhythmia

Cooper Norcross Run the Bridge: More than 4,000 runners participate to support school for the disabled

Valeant Pharmaceuticals announces financial results for the third quarter of 2009

Natus Medical announces a revenue of $44.3M for the third quarter of 2009

New teleneurology medicine program to provide 24-hour emergency services launched

Data from multiple clinical and preclinical studies evaluating Hematide announced

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Valeant Pharmaceuticals to acquire prescription and cosmetic products rights from Polish

Eisai reports global Phase III study results of eribulin mesylate

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

Case Western Reserve awarded $14.7M to lead study on effects of lowering systolic blood pressure

Research project to improve early diagnosis and treatment of mild traumatic brain injuries

Dr. Heather Greene to receive 2009 C.A.R.E. Pharmacy Award

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Ipsen announces sales highlights for the first nine months of 2009

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Neurology News and Research

Latest Neurology News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in